Role of Senescent Cells in Radiation-induced Pulmonary Fibrosis

衰老细胞在辐射诱发的肺纤维化中的作用

基本信息

  • 批准号:
    9976476
  • 负责人:
  • 金额:
    $ 37.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-20 至 2022-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY / ABSTRACT This application is in response to NCI Provocative Question (PQ) 9 to test an innovative hypothesis that senescent cells (SCs) induced by ionizing radiation (IR), particularly senescent type 2 alveolar epithelial cells (AEC2s), are the perpetuators primarily responsible for initiating pathogenesis and driving progression of radiation-induced pulmonary fibrosis (RIPF); therefore, clearance of SCs with a senolytic drug that selectively kills SCs can prevent RIPF and/or delay its progression and, more importantly, reverse existing tissue fibrosis, even after RIPF becomes a progressive disease. This hypothesis is based on the long-term understanding of tissue fibrosis pathogenesis and the exciting new findings about the role of SCs in pulmonary fibrosis, including RIPF. Specifically, pulmonary fibrosis is a disease caused by aberrant wound healing responses that are presumably initiated by cellular senescence induction in AEC2s, which are considered alveolar stem cells (ASCs). This process causes AEC2 defects in self-renewal and differentiation and an inability to generate AECs for maintenance of the alveolar epithelial barrier and to repair damaged lung epithelium. Senescent AEC2s also produce increased levels of reactive oxygen species and release an array of proinflammatory and profibrotic factors, as a result of senescence-associated secretory phenotype (SASP) expression, which may initiate and perpetuate pulmonary fibrosis development by inducing chronic oxidative stress and inflammation and promoting abnormal repair of tissue injury. This is supported by the findings that (1) AEC2 senescence, induced by AEC2-specific deletion of telomeric repeat-binding factor 2 (Trf2), in adult mice causes ASC failure, provokes pulmonary inflammation and fibrotic responses, and sensitizes mice to bleomycin- induced pulmonary fibrosis and (2) cellular senescence inhibition can prevent RIPF and delay bleomycin-induced pulmonary fibrosis progression. Our preliminary studies showed that treatment of the thoracic irradiated mice with ABT-263, a specific Bcl-2/xl inhibitor and a newly discovered senolytic drug by our group, almost completely reversed RIPF, even when ABT-263 treatment was delayed until RIPF was established. To our knowledge, this is the first study to demonstrate that RIPF can be reversed by a drug after it becomes a progressive disease. From these novel findings, we will test our hypothesis through the following specific aims using our well- established thoracic irradiation mouse model: (1) validate that SCs are the perpetuators primarily responsible for initiating pathogenesis and driving progression of RIPF; (2) elucidate the mechanisms by which clearance of SCs prevents and reverses RIPF; and (3) develop a safer and more effective senolytic drug treatment for RIPF. RIPF is one of the most deleterious late effects of thoracic radiotherapy. Our proposed studies will lead to the identification of the underlying mechanisms whereby IR causes pulmonary fibrosis and development of an innovative mechanism-based therapy that can not only prevent and/or delay RIPF but also reverse RIPF.
项目摘要/摘要 此应用程序是对NCI挑衅性问题(PQ)9的回应,以测试一个创新假设 电离辐射诱导的衰老细胞,尤其是衰老的2型肺泡上皮细胞 细胞(AEC2)是永久体,主要负责启动致病和驱动 放射性肺纤维化(RIPF)的进展;因此,用感觉剂清除干细胞 选择性杀死干细胞的药物可以预防RIPF和/或延缓其进展,更重要的是, 逆转现有的组织纤维化,即使在RIPF成为进展性疾病之后也是如此。这一假设是有根据的 关于组织纤维化发病机制的长期认识和关于其作用的令人振奋的新发现 SCS在肺纤维化中的作用,包括RIPF。具体地说,肺纤维化是一种由异常 创伤修复反应可能是由AEC2的细胞衰老诱导启动的,这是 被认为是肺泡干细胞(ASC)。这一过程导致AEC2在自我更新和分化方面存在缺陷 以及不能产生AEC以维持肺泡上皮屏障和修复受损的肺 上皮组织。衰老的AEC2还会产生更多的活性氧物种,并释放出一系列 由衰老相关分泌表型(SASP)引起的促炎和促纤维化因子 表达,可能通过诱导慢性氧化而启动和维持肺纤维化的发展 应激和炎症,促进组织损伤的异常修复。这得到了以下发现的支持:(1) AEC2特异性缺失端粒重复序列结合因子2(TRF2)诱导成年小鼠AEC2衰老 导致ASC衰竭,引发肺部炎症和纤维化反应,并使小鼠对博莱霉素敏感。 诱导的肺纤维化和(2)细胞衰老抑制可预防RIPF并延缓博莱霉素性肺纤维化 肺纤维化进展。我们的初步研究表明,对胸部照射的小鼠的治疗 用ABT-263,一种特异性的Bcl2/XL抑制剂和我们小组新发现的感觉剂,几乎完全 逆转RIPF,即使ABT-263治疗被推迟到RIPF建立时也是如此。据我们所知,这 是第一项证明RIPF在成为进展性疾病后可以被药物逆转的研究。 从这些新发现中,我们将使用我们的井通过以下具体目标来检验我们的假设: 建立胸部照射小鼠模型:(1)验证干细胞是主要负责的永久体 启动RIPF的发病机制和推动进展;(2)阐明RIPF清除 SCS预防和逆转RIPF;以及(3)开发一种更安全、更有效的RIPF抗过敏药物治疗。 RIPF是胸部放射治疗最有害的后遗症之一。我们建议的研究将导致 IR导致肺纤维化和AN发生的潜在机制 创新的基于机制的疗法,不仅可以预防和/或延迟RIPF,而且可以逆转RIPF。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAOHONG ZHOU其他文献

DAOHONG ZHOU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAOHONG ZHOU', 18)}}的其他基金

Proteolysis-targeting chimera against BCL-XL inhibits breast cancer metastasis
针对 BCL-XL 的蛋白水解靶向嵌合体抑制乳腺癌转移
  • 批准号:
    10390383
  • 财政年份:
    2021
  • 资助金额:
    $ 37.67万
  • 项目类别:
Proteolysis-targeting chimera against BCL-XL inhibits breast cancer metastasis
针对 BCL-XL 的蛋白水解靶向嵌合体抑制乳腺癌转移
  • 批准号:
    10198532
  • 财政年份:
    2021
  • 资助金额:
    $ 37.67万
  • 项目类别:
Proteolysis-targeting chimera against BCL-XL inhibits breast cancer metastasis
针对 BCL-XL 的蛋白水解靶向嵌合体抑制乳腺癌转移
  • 批准号:
    10653814
  • 财政年份:
    2021
  • 资助金额:
    $ 37.67万
  • 项目类别:
Role of Senescent Cells in Radiation-induced Pulmonary Fibrosis
衰老细胞在辐射诱发的肺纤维化中的作用
  • 批准号:
    10226299
  • 财政年份:
    2018
  • 资助金额:
    $ 37.67万
  • 项目类别:
Role of Senescent Cells in Radiation-induced Pulmonary Fibrosis
衰老细胞在辐射诱发的肺纤维化中的作用
  • 批准号:
    10644770
  • 财政年份:
    2018
  • 资助金额:
    $ 37.67万
  • 项目类别:
Ionizing radiation induced hematological malignancies
电离辐射诱发的血液系统恶性肿瘤
  • 批准号:
    10722863
  • 财政年份:
    2017
  • 资助金额:
    $ 37.67万
  • 项目类别:
Ionizing radiation induced hematological malignancies
电离辐射诱发的血液系统恶性肿瘤
  • 批准号:
    9899947
  • 财政年份:
    2017
  • 资助金额:
    $ 37.67万
  • 项目类别:
Ionizing radiation induced hematological malignancies
电离辐射诱发的血液系统恶性肿瘤
  • 批准号:
    9216070
  • 财政年份:
    2017
  • 资助金额:
    $ 37.67万
  • 项目类别:
Role of p38 MAPK in HSC Self-Renewal and Radiation-Induced Bone Marrow Injury
p38 MAPK 在 HSC 自我更新和辐射诱导的骨髓损伤中的作用
  • 批准号:
    8072241
  • 财政年份:
    2010
  • 资助金额:
    $ 37.67万
  • 项目类别:
Flow Cytometry & Cell Sorting
流式细胞仪
  • 批准号:
    7944519
  • 财政年份:
    2009
  • 资助金额:
    $ 37.67万
  • 项目类别:

相似海外基金

Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
  • 批准号:
    10751760
  • 财政年份:
    2024
  • 资助金额:
    $ 37.67万
  • 项目类别:
The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 37.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
  • 批准号:
    10726763
  • 财政年份:
    2023
  • 资助金额:
    $ 37.67万
  • 项目类别:
Mechanistic studies of the genetic contribution of desmoplakin to pulmonary fibrosis in alveolar type 2 cells
桥粒斑蛋白对肺泡2型细胞肺纤维化的遗传贡献机制研究
  • 批准号:
    10736228
  • 财政年份:
    2023
  • 资助金额:
    $ 37.67万
  • 项目类别:
Utilizing induced pluripotent stem cells to study the role of alveolar type 2 cell dysfunction in pulmonary fibrosis
利用诱导多能干细胞研究肺泡2型细胞功能障碍在肺纤维化中的作用
  • 批准号:
    10591174
  • 财政年份:
    2023
  • 资助金额:
    $ 37.67万
  • 项目类别:
Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndrome
肝肺综合征低氧血症的新肺泡机制
  • 批准号:
    10718446
  • 财政年份:
    2023
  • 资助金额:
    $ 37.67万
  • 项目类别:
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
  • 批准号:
    10677169
  • 财政年份:
    2023
  • 资助金额:
    $ 37.67万
  • 项目类别:
Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling
酒精和电子烟通过嘌呤受体信号传导引起血脑和肺泡内皮屏障损伤
  • 批准号:
    10638221
  • 财政年份:
    2023
  • 资助金额:
    $ 37.67万
  • 项目类别:
Alveolar Epithelial Cell Dysfunction Induced By Flavored E-Cigarette Aerosols
加味电子烟气雾剂引起的肺泡上皮细胞功能障碍
  • 批准号:
    10770080
  • 财政年份:
    2023
  • 资助金额:
    $ 37.67万
  • 项目类别:
Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung disease
描述let-7 microRNA对肺AT2细胞稳态、肺泡再生和间质性肺疾病的作用
  • 批准号:
    10634881
  • 财政年份:
    2023
  • 资助金额:
    $ 37.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了